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3We describe a female infant born by Caesarean sec-
tion to a healthy 24-year-old G1/P1 at 39 3/7 weeks of 
gestation. The course of the pregnancy had been un-
eventful up to the day of birth when fetal ultrasound 
examination revealed a nonspecific abdominal mass 
(Fig. 1). In addition, cardiomegaly with right ventricular 
hyper trophy and tricuspid insufficiency were seen. 
These findings, along with pathologic Doppler indices 
of the umbilical arteries and a suspicious CTG tracing, 
contributed to the decision to perform a Caesarean 
section.
Apgar scores were 8, 9, and 9 at 1, 5 and 10 minutes, 
respectively. Arterial umbilical cord pH was 7.26. Due 
to low preductal oxygen saturations supplemental 
oxygen was administered via facemask (maximum 
FiO2 0.4) for 7 minutes. The girl’s birth weight was 
2700 g (P3-5), her length was 46.5 cm and her head 
circumference was 32.0 cm (both below P3). Physi-
cal examination revealed a tense protruding abdomen 
(Fig. 2) with a mass being palpable in the right hemi-
abdomen. Within the first hour of life, the newborn 
developed respiratory distress. Laboratory analyses re-
vealed mild respiratory and metabolic acidosis, normal 
electrolyte values, hypoglycemia of 0.4 mmol/L and 
hyper bilirubinemia of 124 µmol/L. An infusion with 
glucose 10% was started. Following initial stabiliza-
tion the patient was transferred to the Intensive Care 
Unit of the University Children’s Hospital of Zurich for 
further dia g nostic evaluation.
CASE REPORT
4Upon arrival, abdominal ultrasound showed an ex-
tensive inhomogeneous, intrahepatic vascular tumor 
(measuring 9 x 9 x 7 cm) displacing the hepatic par-
enchyma as well as the hepatic vessels (Fig. 3). Within 
the first few hours of life the patient developed hepa-
tic failure (ALT 125 U/L [normal: < 31 U/L]; AST 507 
U/L [normal: < 125 U/L]) leading to hyperbilirubine-
mia (total bilirubin 138 µmol/L [normal: < 68 µmol/L] 
with a conjugated bilirubin of 44 µmol/L [normal: < 30 
µmol/L]) requiring phototherapy and exchange trans-
fusion. Significant coagulopathy (INR 1.7 [normal: < 
1.4]; fibrinogen 0.5 g/L [normal: 1.5-4.5 g/L]; PTT 73 
sec [normal: < 55 sec]; α-fetoprotein not elevated) was 
treated with repetitive substitution of coagulation fac-
tors and platelets. 
Abdominal MRI performed on the third day of life re-
vealed a large inhomogeneous high-flow vascular tu-
mor (diameter of 9 cm) within the right hepatic lobe 
and a small lesion in one segment of the left hepatic 
lobe, with central necrosis and hemorrhage (Fig. 4) 
and multiple intralesional arteriovenous shunts.
The suspected diagnoses were rapidly involuting con-
genital hemangioma (RICH) and kaposiform hemangi-
oendothelioma (KHE). Methylprednisolone and siro-
limus, an immunosuppressive agent frequently used 
after renal transplantation, were started as initial 
therapy. Despite maximum conservative therapy the 
patient developed high-output cardiac failure, pulmo-
5nary hyper tension (caused by volume overload of the 
venous capacitance), and acute renal failure. Follow-
ing multi disciplinary discussions, the interventional 
cardiology team performed endovascular coil emboli-
zation of the intralesional arteriovenous shunts on day 
five of life. 
The coiling succeeded (Fig. 5), but at the end of the 
procedure, copious bleeding from the femoral punc-
ture site was noted, which subsequently produced a 
massive retroperitoneal hematoma, intraabdominal 
bleeding and ultimately hemorrhagic shock. Cardio-
pulmonary resuscitation was performed. Extravasation 
of contrast agent was consistent with the diagnosis of 
a long segment dissection of the external iliac artery. 
The pediatric surgery team performed an emergent 
laparo tomy and was able to tamponade the bleeding 
site, leading to transient stabilization. Severe pulmo-
nary hypertension refractory to inhaled nitric oxide led 
to persistent hypoxemia and subsequent multi-organ 
failure. The patient died a few hours later. 
Autopsy revealed a solitary, cystic and spongy mass 
measuring 9 x 6 x 5 cm, and a satellite focus of 1.5 
cm (Fig. 6). Histology displayed large thin walled ves-
sels congested with fresh blood. The endothelial cells 
were mitotically inactive and expressed CD34, while 
immuno histochemistry was negative for GLUT-1 (Fig. 
7).
6Prenatal ultrasound: large intrahepatic tumor.
Fig. 1
7Infant at birth: protruding abdomen with superficial 
vein enhancement.
Fig. 2
8Abdominal ultrasound scan (DOL 1): large, 
inhomogeneous intrahepatic vascular tumor (9 x 9 
x 7cm) displacing the hepatic parenchyma and the 
hepatic vessels.
Fig. 3
9Fig. 4
Abdominal MRI (DOL 3): large vascular lesion within 
the right hepatic lobe and within one segment of the 
left hepatic lobe, both showing central necrosis and 
hemorrhage (A: coronal view, B: transverse view, C: 
MR angiography).
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Fig. 5
Coil embolization (DOL 5): right hepatic artery with 
its branches and 25 coils.
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Fig. 6
Autopsy: cross section of the liver tumor.
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Histopathology (H&E, left): vascular tumor with 
endothelial cells positive for CD34 (top right) and 
negative for GLUT-1 (bottom right).
Fig. 7
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Neonatal hepatic lesions share a broad differential dia-
gnosis. The three main groups include vascular lesions 
(e.g., arteriovenous malformations and arterioportal 
fistulas), benign tumors (e.g., various forms of heman-
giomas or mesenchymal hamartomas), and malignan-
cies (e.g., hepatoblastomas, angiosarcomas, metasta-
tic neuroblastomas or teratomas) (1).
The current classification of neonatal hepatic heman-
giomas includes three categories: focal/solitary, multi-
focal and diffuse hemangiomas (2). Classic infantile 
hemangiomas (IH) of the liver occur in association with 
multiple cutaneous IH and usually present as multi-
focal or diffuse liver hemangiomatosis (3). Solitary or 
focal liver hemangiomas are known to represent RICH.
Classic IH are characterized by a unique growth pat-
tern: at birth, they are very small or undetectable; 
then, they proliferate for several months, and, final-
ly, begin to involute thereafter (1). In contrast, con-
genital hemangiomas (CH) present with maximal size 
already at birth, usually with high blood flow arteri-
ovenous shunting. CH that shrink rapidly during the 
first months of life are referred to as RICH. CH that 
persist without evidence of shrinking within the first 
1-3 years of life are defined as non-involuting conge-
nital hemangiomas (NICH) (3). 
Hepatic RICH are often clinically silent. Many are only 
detected incidentally on imaging performed for un-
DISCUSSION
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related reasons. Occasionally, hepatic RICH may lead 
to high-output cardiac failure due to arteriovenous 
shunting within the tumor, as was the case in our pa-
tient. Thrombocytopenia, anemia and coagulopathy 
may be present (comparable to the Kasabach-Merritt 
phenomenon KMP); however, in RICH coagulopathy 
is usually not as severe and importantly self-limiting 
within a few weeks after birth. Classic KMP is known 
to occur in children with large kaposiform hemangio-
endotheliomas or tufted angiomas, which prompted 
our initial differential diagnosis. However, kaposiform 
hemangioendotheliomas are very unlikely to develop 
in the liver. 
Another rare complication of hepatic RICH is hepatic 
failure. Of note, most RICH usually do not appear wi-
thin the liver but elsewhere on the body, within the 
skin and soft tissue. Whereas high-output cardiac fai-
lure may occur in any RICH, coagulopathy seems to be 
specific for hepatic localization.
The diagnosis of hepatic RICH in a child or a new-
born is not easy to establish. Clinical presentation may 
be strikingly similar to other forms of hepatic lesions. 
How ever, the following findings are highly characte-
ristic for hepatic RICH: ultrasound imaging showing a 
solitary vascularized mass with minimal internal vas-
cularity and few prominent peripheral vessels (2); MRI 
studies revealing a heterogeneous lesion with calcifi-
cations, central necrosis or hemorrhage and centripe-
15
tal enhancement on gadolinium sequences. A tumor 
biopsy for histopathology is not mandatory for the 
dia gnosis and may be risky. If performed, histopatho-
logy of RICH is characterized by vascular endothelial 
cells positive for CD31 or CD34, enabling the identi-
fication of the vascular nature of the lesion. Unlike in 
IH, GLUT-1 staining is negative in CH (5).
The vast majority of patients diagnosed with RICH 
do not require any treatment, as they remain asym-
ptomatic. Thus, observation is considered the gold 
standard (4). If the lesion does not shrink within one 
month, Roe buck et al. have recommended to perform 
a percutaneous needle biopsy in order to rule out a 
malignancy and to guide further management (6). 
When cardiac failure, thrombocytopenia, anemia, co-
agulopathy or hyperbilirubinemia occur, symptomatic 
conservative therapy should be initiated. Emboliza-
tion, as performed in our patient, is the measure of 
last resort. Typical angiographic features of RICH are 
large and irregular feeding arteries, variable sized an-
eurysms, direct arteriovenous shunts and intravascular 
thrombi (7). 
Although the prognosis of hepatic RICH is overall fa-
vourable, a proportion of patients may develop severe 
associated complications including coagulopathy and 
organ failure. If these complications occur, poor out-
come (including death) correlates with the severity of 
cardiac failure and coagulopathy.
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